CDKN2A and melanoma: According to the melanoma signaling pathway map in the KEGG database, oncogenes including BRAF, NRAS, CDK4, and MITF, and tumor suppressor genes including p53, PTEN, and INK4a/ARF (cyclin-dependent kinase inhibitor 2A, CDKN2A) could be identified [27].